Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symbicort vs Advair and Ventolin onset of effect in asthma
NCT00646620Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2003
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised, double-blind trial of budesonide in asthma (4 arms), sponsored by AstraZeneca. Primary endpoint: Forced Expiratory Volume in 1 Second. Started Apr 2003; status: completed.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00646620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00646620.